Haemonetics (HAE)
NYSE:HAE
Want to see HAE full AI Analyst Report?
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.33B | $ 1.36B | $ 1.31B | $ 1.17B | $ 993.20M |
| Gross Profit | $ 743.59M | $ 778.55M | $ 711.91M | $ 622.87M | $ 530.77M |
| Operating Income | $ 241.40M | $ 221.82M | $ 164.88M | $ 156.03M | $ 80.75M |
| EBITDA | $ 397.12M | $ 355.99M | $ 295.45M | $ 252.01M | $ 191.72M |
| Net Income | $ 97.31M | $ 167.68M | $ 117.56M | $ 115.40M | $ 43.38M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 245.44M | $ 306.76M | $ 178.80M | $ 284.47M | $ 259.50M |
| Total Assets | $ 2.40B | $ 2.45B | $ 2.20B | $ 1.93B | $ 1.86B |
| Total Debt | $ 1.22B | $ 1.22B | $ 807.79M | $ 765.89M | $ 780.78M |
| Net Debt | $ 979.14M | $ 918.02M | $ 628.99M | $ 481.42M | $ 521.29M |
| Total Liabilities | $ 1.60B | $ 1.63B | $ 1.24B | $ 1.12B | $ 1.11B |
| Stockholders' Equity | $ 796.32M | $ 820.84M | $ 959.96M | $ 818.00M | $ 749.42M |
| Cash Flow | |||||
| Free Cash Flow | $ 260.44M | $ 142.45M | $ 115.45M | $ 162.87M | $ 75.75M |
| Operating Cash Flow | $ 293.22M | $ 181.72M | $ 181.75M | $ 273.06M | $ 172.26M |
| Investing Cash Flow | $ -179.55M | $ -161.90M | $ -322.39M | $ -143.79M | $ -86.34M |
| Financing Cash Flow | $ -178.46M | $ 108.82M | $ 38.16M | $ -100.36M | $ -15.75M |